Search research articles
Contact Us
Filters
Showing results (211-220 of 240) with videos related to
Page
of 24
Sort By:
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1
Ian Paterson, David Y-K Chen, Mark J Coster, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
September 13, 2019
Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging
Richard B Thompson, Kelvin Chow, Joseph J Pagano, et al.
Genes, Chromosomes & Cancer
|
April 16, 2003
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis
Carmel Toomes, Andrew Jackson, Kristie Maguire, et al.
ESC Heart Failure
|
June 28, 2020
Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
Jonathan G Howlett, Nakul Sharma, Wendimagegn G Alemayehu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin, John R Mackey, Sheri Koshman, et al.
JACC. Advances
|
June 28, 2024
TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast Cancer
Amy A Kirkham, John R Mackey, Richard B Thompson, et al.
Nature Communications
|
July 27, 2025
Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents
Saymon Tejay, Maria Areli Lorenzana-Carrillo, Guocheng Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 19, 2021
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial
Amy A Kirkham, Edith Pituskin, Richard B Thompson, et al.
ACS Omega
|
July 20, 2018
Structural Determinants of the Dictyostatin Chemotype for Tubulin Binding Affinity and Antitumor Activity Against Taxane- and Epothilone-Resistant Cancer Cells
Chiara Trigili, Isabel Barasoain, Pedro A Sánchez-Murcia, et al.
ESC Heart Failure
|
September 27, 2021
Cardiac remodelling predicts outcome in patients with chronic heart failure
Lingyu Xu, Joseph Pagano, Kelvin Chow, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 240) with videos related to
Sort By:
Page
of 24
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1
Ian Paterson, David Y-K Chen, Mark J Coster, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
September 13, 2019
Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging
Richard B Thompson, Kelvin Chow, Joseph J Pagano, et al.
Genes, Chromosomes & Cancer
|
April 16, 2003
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis
Carmel Toomes, Andrew Jackson, Kristie Maguire, et al.
ESC Heart Failure
|
June 28, 2020
Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
Jonathan G Howlett, Nakul Sharma, Wendimagegn G Alemayehu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin, John R Mackey, Sheri Koshman, et al.
JACC. Advances
|
June 28, 2024
TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast Cancer
Amy A Kirkham, John R Mackey, Richard B Thompson, et al.
Nature Communications
|
July 27, 2025
Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents
Saymon Tejay, Maria Areli Lorenzana-Carrillo, Guocheng Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 19, 2021
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial
Amy A Kirkham, Edith Pituskin, Richard B Thompson, et al.
ACS Omega
|
July 20, 2018
Structural Determinants of the Dictyostatin Chemotype for Tubulin Binding Affinity and Antitumor Activity Against Taxane- and Epothilone-Resistant Cancer Cells
Chiara Trigili, Isabel Barasoain, Pedro A Sánchez-Murcia, et al.
ESC Heart Failure
|
September 27, 2021
Cardiac remodelling predicts outcome in patients with chronic heart failure
Lingyu Xu, Joseph Pagano, Kelvin Chow, et al.
Page
of 24